THURSDAY, May 3, 2018 -- Circulating tumor cell status is predictive of radiotherapy (RT) benefit in early-stage breast cancer, according to a study published online May 3 in JAMA Oncology. Chelain R. Goodman, M.D., Ph.D., from the Northwestern...
Original Article: CTC Status Predicts RT Benefit in Early-Stage Breast Cancer